{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T20:30:35Z","timestamp":1791145835428,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd008953","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2014,10,28]],"date-time":"2014-10-28T00:00:00Z","timestamp":1414454400000}}],"reference-count":72,"publisher":"Wiley","issue":"10","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd008953.pub2","type":"journal-article","created":{"date-parts":[[2014,10,28]],"date-time":"2014-10-28T11:04:44Z","timestamp":1414494284000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Treatment for speech disorder in Friedreich ataxia and other hereditary ataxia syndromes"],"prefix":"10.1002","volume":"2014","author":[{"given":"Adam P","family":"Vogel","sequence":"first","affiliation":[{"name":"University of Melbourne; Speech Neuroscience Unit; 550 Swanston Street Parkville Melbourne Victoria Australia 3010"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Folker","sequence":"additional","affiliation":[{"name":"The University of Queensland; School of Health and Rehabilitation Sciences; Brisbane Queensland Australia 4072"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew L","family":"Poole","sequence":"additional","affiliation":[{"name":"University of Melbourne; Speech Neuroscience Unit; 550 Swanston Street Parkville Melbourne Victoria Australia 3010"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,10,28]]},"reference":[{"issue":"1-2","key":"10.1002\/14651858.CD008953.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jns.2007.04.019","article-title":"Treatment of spinocerebellar ataxia with buspirone","volume":"260","author":"Assadi","year":"2007","journal-title":"Journal of the Neurological Sciences"},{"issue":"12","key":"10.1002\/14651858.CD008953.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1111\/j.1468-1331.2008.02318.x","article-title":"Coenzyme Q10 and vitamin E deficiency in Friedreich's ataxia: predictor of efficacy of vitamin E and coenzyme Q10 therapy","volume":"15","author":"Cooper","year":"2008","journal-title":"European Journal of Neurology"},{"issue":"10","key":"10.1002\/14651858.CD008953.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S1474-4422(07)70220-X","article-title":"Neurological effects of high-dose idebenone in patients with Friedreich's ataxia: a randomised, placebo-controlled trial","volume":"6","author":"Prospero","year":"2007","journal-title":"Lancet Neurology"},{"key":"10.1002\/14651858.CD008953.pub2-BIB0004|cit4","first-page":"199","article-title":"Chronic experimentation with TRH administered intramuscularly in spinocerebellar degeneration. Double-blind cross-over study in 30 subjects","volume-title":"Protirelin Tartrate (TRH-T): Pharmacological and Clinical Studies: Recent Advances and Perspectives","author":"Filla","year":"1988"},{"issue":"2","key":"10.1002\/14651858.CD008953.pub2-BIB0005|cit5","first-page":"83","article-title":"Chronic experimentation with TRH administered intramuscularly in spinocerebellar degeneration. Double-blind cross-over study in 30 subjects","volume":"59","author":"Filla","year":"1989","journal-title":"Rivista di Neurologia"},{"issue":"8","key":"10.1002\/14651858.CD008953.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1001\/archneurol.2010.168","article-title":"A phase 3, double-blind, placebo-controlled trial of idebenone in Friedreich ataxia","volume":"67","author":"Lynch","year":"2010","journal-title":"Archives of Neurology"},{"issue":"8","key":"10.1002\/14651858.CD008953.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1002\/mds.25058","article-title":"A0001 in Friedreich ataxia: biochemical characterization and effects in a clinical trial","volume":"27","author":"Lynch","year":"2012","journal-title":"Movement Disorders"},{"issue":"3","key":"10.1002\/14651858.CD008953.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/mds.24066","article-title":"Erythropoietin in Friedreich ataxia: no effect on frataxin in a randomized controlled trial","volume":"27","author":"Mariotti","year":"2012","journal-title":"Movement Disorders"},{"issue":"5","key":"10.1002\/14651858.CD008953.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1177\/1545968311425918","article-title":"Cerebellar ataxia rehabilitation trial in degenerative cerebellar diseases","volume":"26","author":"Miyai","year":"2012","journal-title":"Neurorehabilitation and Neural Repair"},{"issue":"10","key":"10.1002\/14651858.CD008953.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1212\/WNL.0b013e3181d31e23","article-title":"Riluzole in cerebellar ataxia: a randomized, double-blind, placebo-controlled pilot trial","volume":"74","author":"Ristori","year":"2010","journal-title":"Neurology"},{"issue":"2","key":"10.1002\/14651858.CD008953.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0022-510X(83)90008-4","article-title":"Controlled trial of thyrotropin releasing hormone tartrate in ataxia of spinocerebellar degenerations","volume":"61","author":"Sobue","year":"1983","journal-title":"Journal of the Neurological Sciences"},{"issue":"5","key":"10.1002\/14651858.CD008953.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1001\/archneur.1995.00540290042016","article-title":"Levorotatory form of 5-hydroxytryptophan in Friedreich's ataxia","volume":"52","author":"Trouillas","year":"1995","journal-title":"Archives of Neurology"},{"issue":"5","key":"10.1002\/14651858.CD008953.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1001\/archneur.1995.00540290037015","article-title":"Double-blind crossover study with levorotatory form of hydroxytryptophan in patients with degenerative cerebellar diseases","volume":"52","author":"Wessel","year":"1995","journal-title":"Archives of Neurology"},{"issue":"10","key":"10.1002\/14651858.CD008953.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1002\/mds.25126","article-title":"A randomized trial of oral betamethasone to reduce ataxia symptoms in ataxia telangiectasia","volume":"27","author":"Zannolli","year":"2012","journal-title":"Movement Disorders"},{"issue":"8","key":"10.1002\/14651858.CD008953.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1212\/WNL.0b013e318247cc7a","article-title":"A randomized trial of varenicline (Chantix) for the treatment of spinocerebellar ataxia type 3","volume":"78","author":"Zesiewicz","year":"2012","journal-title":"Neurology"},{"issue":"4","key":"10.1002\/14651858.CD008953.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"169","DOI":"10.4414\/sanp.2006.01730","article-title":"Expanding view of phenotype and oxidative stress in Friedreich's ataxia patients with and without idebenone","volume":"157","author":"Arnold","year":"2006","journal-title":"Schweizer Archiv f\u00fcr Neurologie und Psychiatrie"},{"issue":"4","key":"10.1002\/14651858.CD008953.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1055\/s-2002-34494","article-title":"Friedreich's ataxia: idebenone treatment in early stage patients","volume":"33","author":"Artuch","year":"2002","journal-title":"Neuropediatrics"},{"issue":"1-2","key":"10.1002\/14651858.CD008953.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jns.2006.01.021","article-title":"Cerebellar ataxia with coenzyme Q10 deficiency: diagnosis and follow-up after coenzyme Q10 supplementation","volume":"246","author":"Artuch","year":"2006","journal-title":"Journal of the Neurological Sciences"},{"issue":"5","key":"10.1002\/14651858.CD008953.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/ana.21177","article-title":"Friedreich's ataxia: clinical pilot trial with recombinant human erythropoietin","volume":"62","author":"Boesch","year":"2007","journal-title":"Annals of Neurology"},{"issue":"13","key":"10.1002\/14651858.CD008953.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1002\/mds.22294","article-title":"Neurological effects of recombinant human erythropoietin in Friedreich's ataxia: a clinical pilot trial","volume":"23","author":"Boesch","year":"2008","journal-title":"Movement Disorders"},{"issue":"5","key":"10.1002\/14651858.CD008953.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.neurol.2008.02.032","article-title":"Steroid treatment in four cases of anti-GAD cerebellar ataxia","volume":"164","author":"Bonnan","year":"2008","journal-title":"Revue Neurologique"},{"issue":"3","key":"10.1002\/14651858.CD008953.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1136\/jnnp.61.3.259","article-title":"Amantadine hydrochloride treatment in heredodegenerative ataxias: a double blind study","volume":"61","author":"Botez","year":"1996","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"issue":"8","key":"10.1002\/14651858.CD008953.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1001\/archneur.1997.00550200086015","article-title":"Can we treat respiratory failure in Friedreich ataxia?","volume":"54","author":"Botez","year":"1997","journal-title":"Archives of Neurology"},{"issue":"3","key":"10.1002\/14651858.CD008953.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1468-1331.2008.02060.x","article-title":"Steroid-induced improvement of neurological signs in ataxia-telangiectasia patients","volume":"15","author":"Broccoletti","year":"2008","journal-title":"European Journal of Neurology"},{"issue":"9","key":"10.1002\/14651858.CD008953.pub2-BIB0025|cit25","first-page":"32","article-title":"The use of noben for correction of mitochondrial disorders in Friedrich's disease","volume":"107","author":"Ershova","year":"2007","journal-title":"Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova"},{"issue":"1-2","key":"10.1002\/14651858.CD008953.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jns.2008.03.016","article-title":"The efficacy of combined estrogen and buspirone treatment in olivopontocerebellar atrophy","volume":"271","author":"Heo","year":"2008","journal-title":"Journal of the Neurological Sciences"},{"issue":"20","key":"10.1002\/14651858.CD008953.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1212\/WNL.0b013e3182749e67","article-title":"Video game\u2013based coordinative training improves ataxia in children with degenerative ataxia","volume":"79","author":"Ilg","year":"2012","journal-title":"Neurology"},{"issue":"3","key":"10.1002\/14651858.CD008953.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.ahj.2010.10.038","article-title":"Idebenone in Friedreich ataxia cardiomyopathy\u2014results from a 6-month phase III study (IONIA)","volume":"161","author":"Lagedrost","year":"2011","journal-title":"American Heart Journal"},{"issue":"2","key":"10.1002\/14651858.CD008953.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s00415-011-6174-y","article-title":"Assessment of neurological efficacy of idebenone in pediatric patients with Friedreich's ataxia: data from a 6-month controlled study followed by a 12-month open-label extension study","volume":"259","author":"Meier","year":"2012","journal-title":"Journal of Neurology"},{"issue":"2","key":"10.1002\/14651858.CD008953.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1017\/S0317167100043870","article-title":"Oral lecithin and linoleic acid in Friedreich's ataxia: II. Clinical results","volume":"9","author":"Melancon","year":"1982","journal-title":"Canadian Journal of Neurological Sciences"},{"issue":"1-2","key":"10.1002\/14651858.CD008953.pub2-BIB0031|cit31","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.jns.2008.12.017","article-title":"Spinocerebellar ataxia type 6 (SCA6): clinical pilot trial with gabapentin","volume":"278","author":"Nakamura","year":"2009","journal-title":"Journal of the Neurological Sciences"},{"issue":"1-2","key":"10.1002\/14651858.CD008953.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0022-510X(03)00009-1","article-title":"D-cycloserine for the treatment of ataxia in spinocerebellar degeneration","volume":"210","author":"Ogawa","year":"2003","journal-title":"Journal of the Neurological Sciences"},{"issue":"6","key":"10.1002\/14651858.CD008953.pub2-BIB0033|cit33","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.ejpn.2007.11.006","article-title":"Idebenone treatment in paediatric and adult patients with Friedreich ataxia: long-term follow-up","volume":"12","author":"Pineda","year":"2008","journal-title":"European Journal of Paediatric Neurology"},{"issue":"3","key":"10.1002\/14651858.CD008953.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1620\/tjem.189.203","article-title":"Therapeutic efficacy of transcranial magnetic stimulation for hereditary spinocerebellar degeneration","volume":"189","author":"Shimizu","year":"1999","journal-title":"Tohoku Journal of Experimental Medicine"},{"issue":"8165","key":"10.1002\/14651858.CD008953.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S0140-6736(80)90963-0","article-title":"Effect of thyrotropin-releasing hormone on ataxia of spinocerebellar degeneration","volume":"315","author":"Sobue","year":"1980","journal-title":"Lancet"},{"issue":"3","key":"10.1002\/14651858.CD008953.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1212\/WNL.0b013e318225ab07","article-title":"A randomized trial of 4-aminopyridine in EA2 and related familial episodic ataxias","volume":"77","author":"Strupp","year":"2011","journal-title":"Neurology"},{"issue":"3","key":"10.1002\/14651858.CD008953.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/BF02043955","article-title":"Regression of cerebellar syndrome with long-term administration of 5-HTP or the combination 5-HTP-benserazide","volume":"5","author":"Trouillas","year":"1984","journal-title":"Italian Journal of Neurological Sciences"},{"issue":"6","key":"10.1002\/14651858.CD008953.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1001\/archneur.1997.00550180059013","article-title":"Buspirone, a 5-hydroxytryptamine1A agonist, is active in cerebellar ataxia. Results of a double-blind drug placebo study in patients with cerebellar cortical atrophy","volume":"54","author":"Trouillas","year":"1997","journal-title":"Archives of Neurology"},{"issue":"1","key":"10.1002\/14651858.CD008953.pub2-BIB0039|cit39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12311-010-0212-7","article-title":"Combined therapy with idebenone and deferiprone in patients with Friedreich's ataxia","volume":"10","author":"Velasco-S\u00e1nchez","year":"2011","journal-title":"Cerebellum"},{"issue":"8","key":"10.1002\/14651858.CD008953.pub2-BIB0040|cit40","first-page":"793","article-title":"A clinical trial of acetazolamide for SCA6","volume":"39","author":"Yabe","year":"1999","journal-title":"Rinsho Shinkeigaku (Clinical Neurology)"},{"key":"10.1002\/14651858.CD008953.pub2-BIB0041|cit41","unstructured":"EUCTR 2009-016317-20-IT Pilot study to assess safety and tolerability of lithium on spinocerebellar ataxia of type 2 - lithium in SCA2 http:\/\/apps.who.int\/trialsearch\/Trial2.aspx?TrialID=EUCTR2009-016317-20-IT"},{"key":"10.1002\/14651858.CD008953.pub2-BIB0042|cit42","unstructured":"EUCTR 2012-005312-26-DE Sustained release 4-aminopyridine (Fampyra\u00ae) in cerebellar gait disorder http:\/\/apps.who.int\/trialsearch\/Trial2.aspx?TrialID=EUCTR2012-005312-26-DE"},{"key":"10.1002\/14651858.CD008953.pub2-BIB0043|cit43","first-page":"S153","article-title":"12-month European phase III clinical study of SNT-MC17\/idebenone in the treatment of Friedreich\u2019s ataxia: baseline neurology data and interim safety results","volume":"256 Suppl 2","author":"Schulz","year":"2009","journal-title":"Journal of Neurology"},{"issue":"5254","key":"10.1002\/14651858.CD008953.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1126\/science.271.5254.1423","article-title":"Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion","volume":"271","author":"Campuzano","year":"1996","journal-title":"Science"},{"issue":"3","key":"10.1002\/14651858.CD008953.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1017\/S1355617703930074","article-title":"The effects of practice on the cognitive test performance of neurologically normal individuals assessed at brief test-retest intervals","volume":"9","author":"Collie","year":"2003","journal-title":"Journal of the International Neuropsychological Society"},{"issue":"2","key":"10.1002\/14651858.CD008953.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/(SICI)1096-8628(19991119)87:2<168::AID-AJMG8>3.0.CO;2-2","article-title":"Clinical and genetic study of Friedreich ataxia in an Australian population","volume":"87","author":"Delatycki","year":"1999","journal-title":"American Journal of Medical Genetics"},{"issue":"1","key":"10.1002\/14651858.CD008953.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/jmg.37.1.1","article-title":"Friedreich ataxia: an overview","volume":"37","author":"Delatycki","year":"2000","journal-title":"Journal of Medical Genetics"},{"key":"10.1002\/14651858.CD008953.pub2-BIB0048|cit48","volume-title":"Motor Speech Disorders: Substrates, Differential Diagnosis, and Management","author":"Duffy","year":"2013"},{"issue":"16","key":"10.1002\/14651858.CD008953.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1056\/NEJM199610173351601","article-title":"Clinical and genetic abnormalities in patients with Friedreich's ataxia","volume":"335","author":"D\u00fcrr","year":"1996","journal-title":"New England Journal of Medicine"},{"issue":"19","key":"10.1002\/14651858.CD008953.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1212\/WNL.0b013e318257ea5d","article-title":"A randomized trial of varenicline (Chantix) for the treatment of spinocerebellar ataxia type 3","volume":"78","author":"Filla","year":"2012","journal-title":"Neurology"},{"issue":"3","key":"10.1002\/14651858.CD008953.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1159\/000287207","article-title":"Dysarthria in Friedreich\u2019s ataxia: a perceptual analysis","volume":"62","author":"Folker","year":"2010","journal-title":"Folia Phoniatrica et Logopaedia"},{"key":"10.1002\/14651858.CD008953.pub2-BIB0052|cit52","doi-asserted-by":"publisher","first-page":"f7062","DOI":"10.1136\/bmj.f7062","article-title":"Friedreich ataxia","volume":"347","author":"Gibilisco","year":"2013","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD008953.pub2-BIB0053|cit53","unstructured":"Jan Brozek, Andrew Oxman, Holger Sch\u00fcnemann GRADEpro 2008"},{"issue":"3","key":"10.1002\/14651858.CD008953.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/brain\/104.3.589","article-title":"Friedreich's ataxia: a clinical and genetic study of 90 families with an analysis of early diagnostic criteria and intrafamilial clustering of clinical features","volume":"104","author":"Harding","year":"1981","journal-title":"Brain"},{"issue":"1","key":"10.1002\/14651858.CD008953.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000111799","article-title":"Living with dysarthria: evaluation of a self-report questionnaire","volume":"60","author":"Hartelius","year":"2007","journal-title":"Folia Phoniatrica et Logopaedica"},{"key":"10.1002\/14651858.CD008953.pub2-BIB0056|cit56","unstructured":"Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"4","key":"10.1002\/14651858.CD008953.pub2-BIB0057|cit57","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007791.pub2","article-title":"Antioxidants and other pharmacological treatments for Friedreich ataxia","author":"Kearney","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD008953.pub2-BIB0058|cit58","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006279.pub2","article-title":"Intervention for dysarthria associated with acquired brain injury in children and adolescents","author":"Morgan","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD008953.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.biopsych.2012.03.015","article-title":"Vocal acoustic biomarkers of depression severity and treatment response","volume":"72","author":"Mundt","year":"2012","journal-title":"Biological Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD008953.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/ng0793-221","article-title":"Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type-1","volume":"4","author":"Orr","year":"1993","journal-title":"Nature Genetics"},{"issue":"4","key":"10.1002\/14651858.CD008953.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1136\/jnnp.71.4.493","article-title":"Intensive voice treatment (LSVT) for patients with Parkinson's disease: a 2 year follow up","volume":"71","author":"Ramig","year":"2001","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"key":"10.1002\/14651858.CD008953.pub2-BIB0062|cit62","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"issue":"11","key":"10.1002\/14651858.CD008953.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1007\/s00415-012-6547-x","article-title":"Longitudinal change in dysarthria associated with Friedreich ataxia: a potential clinical endpoint","volume":"259","author":"Rosen","year":"2012","journal-title":"Journal of Neurology"},{"issue":"1","key":"10.1002\/14651858.CD008953.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/14015430600789203","article-title":"Perceptual and acoustic analysis of speech in individuals with spinocerebellar ataxia (SCA)","volume":"32","author":"Schalling","year":"2007","journal-title":"Logopedics, Phoniatrics, Vocology"},{"issue":"Pt 12","key":"10.1002\/14651858.CD008953.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1093\/brain\/120.12.2131","article-title":"Friedreich's ataxia. Revision of the phenotype according to molecular genetics","volume":"120","author":"Sch\u00f6ls","year":"1997","journal-title":"Brain"},{"issue":"11","key":"10.1002\/14651858.CD008953.pub2-BIB0066|cit66","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1002\/mds.23103","article-title":"Assessment of impairment or monitoring change in Friedreich Ataxia","volume":"25","author":"Vogel","year":"2010","journal-title":"Movement Disorders"},{"issue":"6","key":"10.1002\/14651858.CD008953.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"3747","DOI":"10.1121\/1.3506349","article-title":"Acoustic analysis of the effect of sustained wakefulness on speech","volume":"128","author":"Vogel","year":"2010","journal-title":"Journal of the Acoustical Society of America"},{"issue":"2","key":"10.1002\/14651858.CD008953.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jvoice.2009.09.003","article-title":"Reliability, stability, and sensitivity to change and impairment in acoustic measures of timing and frequency","volume":"25","author":"Vogel","year":"2011","journal-title":"Journal of Voice"},{"issue":"1","key":"10.1002\/14651858.CD008953.pub2-BIB0069|cit69","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008953","article-title":"Treatment for speech disorder in Friedreich ataxia and other hereditary ataxia syndromes","author":"Vogel","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"14","key":"10.1002\/14651858.CD008953.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1016\/j.neuropsychologia.2012.09.011","article-title":"Speech acoustic markers of early stage and prodromal Huntington's disease: a marker of disease onset?","volume":"50","author":"Vogel","year":"2012","journal-title":"Neuropsychologia"},{"issue":"2","key":"10.1002\/14651858.CD008953.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3109\/14015439.2013.775332","article-title":"Monitoring change requires a re-think of assessment practices in voice and speech","volume":"39","author":"Vogel","year":"2014","journal-title":"Logopedics, Phoniatrics, Vocology"},{"key":"10.1002\/14651858.CD008953.pub2-BIB0072|cit72","unstructured":"World Health Organization International Classification of Functioning, Disability and Health (ICF) Geneva: World Health Organization 2001"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD008953.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,29]],"date-time":"2024-06-29T06:47:20Z","timestamp":1719643640000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD008953.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Neuromuscular Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,10,28]]},"references-count":72,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2014,10]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd008953.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,28]]}}}